This company listing is no longer active
Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!
Acorda Therapeutics Yönetim
Yönetim kriter kontrolleri 2/4
Acorda Therapeutics' CEO is Ron Cohen, appointed in Jan 1995, has a tenure of 29.5 years. total yearly compensation is $996.33K, comprised of 62.7% salary and 37.3% bonuses, including company stock and options. directly owns 0.6% of the company’s shares, worth €1.14K. The average tenure of the management team and the board of directors is 6.2 years and 21 years respectively.
Anahtar bilgiler
Ron Cohen
İcra Kurulu Başkanı
US$996.3k
Toplam tazminat
| CEO maaş yüzdesi | 62.7% |
| CEO görev süresi | 29.5yrs |
| CEO sahipliği | 0.6% |
| Yönetim ortalama görev süresi | 6.2yrs |
| Yönetim Kurulu ortalama görev süresi | 21yrs |
Son yönetim güncellemeleri
Recent updates
CEO Tazminat Analizi
| Tarih | Toplam Tazminat | Maaş | Şirket Kazançları |
|---|---|---|---|
| Mar 31 2024 | n/a | n/a | -US$263m |
| Dec 31 2023 | US$996k | US$625k | -US$253m |
| Sep 30 2023 | n/a | n/a | -US$16m |
| Jun 30 2023 | n/a | n/a | -US$21m |
| Mar 31 2023 | n/a | n/a | -US$58m |
| Dec 31 2022 | US$984k | US$625k | -US$66m |
| Sep 30 2022 | n/a | n/a | -US$106m |
| Jun 30 2022 | n/a | n/a | -US$119m |
| Mar 31 2022 | n/a | n/a | -US$95m |
| Dec 31 2021 | US$2m | US$743k | -US$104m |
| Sep 30 2021 | n/a | n/a | -US$166m |
| Jun 30 2021 | n/a | n/a | -US$132m |
| Mar 31 2021 | n/a | n/a | -US$127m |
| Dec 31 2020 | US$2m | US$796k | -US$100m |
| Sep 30 2020 | n/a | n/a | US$49m |
| Jun 30 2020 | n/a | n/a | -US$222m |
| Mar 31 2020 | n/a | n/a | -US$232m |
| Dec 31 2019 | US$2m | US$796k | -US$273m |
| Sep 30 2019 | n/a | n/a | -US$329m |
| Jun 30 2019 | n/a | n/a | -US$79m |
| Mar 31 2019 | n/a | n/a | -US$6m |
| Dec 31 2018 | US$2m | US$796k | US$34m |
| Sep 30 2018 | n/a | n/a | -US$147m |
| Jun 30 2018 | n/a | n/a | -US$158m |
| Mar 31 2018 | n/a | n/a | -US$213m |
| Dec 31 2017 | US$2m | US$792k | -US$223m |
Tazminat ve Piyasa: Ron's total compensation ($USD996.33K) is above average for companies of similar size in the German market ($USD515.52K).
Tazminat ve Kazançlar: Ron's compensation has increased whilst the company is unprofitable.
CEO
Ron Cohen (68 yo)
29.5yrs
Görev süresi
US$996,328
Tazminat
Dr. Ron Cohen, M.D., serves as an Independent Director of ZWI Therapeutics, Inc. since January 2024. He has been the Founder of Acorda Therapeutics, Inc. since 1995 and has been its Chief Executive Officer...
Liderlik Ekibi
| İsim | Pozisyon | Görev süresi | Tazminat | Sahiplik |
|---|---|---|---|---|
| Founder | 29.5yrs | US$996.33k | 0.60% $ 1.1k | |
| CFO & Treasurer | 2.7yrs | US$611.55k | 0% $ 0 | |
| General Counsel & Corporate Secretary | 2.7yrs | US$661.57k | 0% $ 0 | |
| Executive Vice President of Human Resources | 9.5yrs | Veri yok | Veri yok | |
| Chief Commercial Officer | 2.8yrs | US$592.23k | 0.041% $ 76.9 | |
| Senior VP of Operations & Strategic Planning | no data | Veri yok | Veri yok | |
| Senior VP of Drug Development & Regulatory Affairs | no data | Veri yok | Veri yok | |
| Special Scientific Advisor | no data | US$10.00k | Veri yok |
6.2yrs
Ortalama Görev Süresi
64yo
Ortalama Yaş
Deneyimli Yönetim: CDG's management team is seasoned and experienced (6.2 years average tenure).
Yönetim Kurulu Üyeleri
| İsim | Pozisyon | Görev süresi | Tazminat | Sahiplik |
|---|---|---|---|---|
| Founder | 29.5yrs | US$996.33k | 0.60% $ 1.1k | |
| Independent Director | 2.5yrs | US$94.71k | 0% $ 0 | |
| Member of Scientific Advisory Board | no data | Veri yok | Veri yok | |
| Independent Director | 26.5yrs | US$82.65k | 0.0019% $ 3.7 | |
| Member of Scientific Advisory Board | no data | Veri yok | Veri yok | |
| Member of Scientific Advisory Board | no data | Veri yok | Veri yok | |
| Member of Scientific Advisory Board | no data | Veri yok | Veri yok | |
| Member of Scientific Advisory Board | no data | Veri yok | Veri yok | |
| Member of Scientific Advisory Board | no data | Veri yok | Veri yok | |
| Member of Scientific Advisory Board | no data | Veri yok | Veri yok | |
| Member of Scientific Advisory Board | no data | Veri yok | Veri yok | |
| Independent Non-Executive Chairman | 15.6yrs | US$140.22k | 0% $ 0 |
21.0yrs
Ortalama Görev Süresi
70yo
Ortalama Yaş
Deneyimli Yönetim Kurulu: CDG's board of directors are seasoned and experienced ( 21 years average tenure).